Skip to main content
Caplight Logo









Tempo Bioscience, Inc.

Tempo Bioscience, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://tempobioscience.com

Last Round

Grant

Mar 10, 2025

Total Funding Raised

$17.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Tempo Bioscience, Inc. is a biotechnology company that develops human induced pluripotent stem cell (iPSC)-based models and proprietary biosensor technologies for drug discovery, preclinical development, and diagnostic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

induced pluripotent stem cellsiPSCbiosensor assayspreclinical drug discoverytoxicology testinganimal-free testingin vitro modelslive-cell imagingdisease modelingdrug efficacyregenerative medicinecustom cell engineeringorgan-on-a-chipalternative methods3Rs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tempo Bioscience, Inc. Comparables

Compare Tempo Bioscience, Inc. with similar companies based on industry and business-model similarity.

Tempo Bioscience, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iXCells Biotechnologies
84%
Axol Bioscience
84%
Greenstone Biosciences
83%

Tempo Bioscience, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 10, 2025
Series AMar 19, 2024
VC RoundSep 25, 2020

Tempo Bioscience, Inc. Investors

Notable investors and investment history

Tempo Bioscience, Inc. investors
InvestorRounds
NIH RADxGrant
AJAX Capital PartnersSeries A
Johnson & Johnson Innovation – JJDCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 6, 6x the trailing average.

  • Jun 18, 2026

    Monthly visitors increased 48% MoM, reaching 7.7K.

Tempo Bioscience, Inc. Filings

Explore SEC and related filing metadata, where available.

Tempo Bioscience, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tempo Bioscience, Inc.'s valuation, stock price, and market status.

Is Tempo Bioscience, Inc. a public or private company?

Tempo Bioscience, Inc. is a private company.

What is the current stock price of Tempo Bioscience, Inc.?

Tempo Bioscience, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Tempo Bioscience, Inc. worth (valuation)?

Valuation information for Tempo Bioscience, Inc. is not publicly available.

Can I buy Tempo Bioscience, Inc. stock?

Tempo Bioscience, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tempo Bioscience, Inc.'s last funding round?

Tempo Bioscience, Inc.'s most recent funding round was Grant on March 10, 2025.

Who are the main investors in Tempo Bioscience, Inc.?

Key investors in Tempo Bioscience, Inc. include Johnson & Johnson Innovation – JJDC.

Will Tempo Bioscience, Inc. IPO soon?

No public IPO plans have been announced for Tempo Bioscience, Inc..

How can I track Tempo Bioscience, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tempo Bioscience, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2013
Last FundingMar 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?